Morgan Stanley Evogene Ltd. Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Evogene Ltd. stock. As of the latest transaction made, Morgan Stanley holds 218,455 shares of EVGN stock, worth $500,261. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218,455

Previous 284,048 23.09%

Holding current value

$500,261

Previous $213,000 33.8%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$0.61 - $0.82 $40,011 - $53,786	-65,593 Reduced 23.09%	218,455 $141,000
Q2 2024 Aug 14, 2024	SELL	$0.61 - $0.82 $40,011 - $53,786	-65,593 Reduced 23.09%	218,455 $141,000
Q1 2024 Oct 17, 2024	BUY	$0.7 - $0.98 $45,915 - $64,281	65,593 Added 30.03%	284,048 $213,000
Q1 2024 Aug 16, 2024	BUY	$0.7 - $0.98 $66,921 - $93,689	95,602 Added 50.73%	284,048 $213,000
Q1 2024 May 15, 2024	BUY	$0.7 - $0.98 $66,921 - $93,689	95,602 Added 50.73%	284,048 $213,000
Q4 2023 Aug 16, 2024	SELL	$0.47 - $0.88 $14,104 - $26,407	-30,009 Reduced 13.74%	188,446 $158,000
Q4 2023 Feb 13, 2024	BUY	$0.47 - $0.88 $5,936 - $11,115	12,631 Added 7.18%	188,446 $158,000
Q3 2023 Nov 15, 2023	BUY	$0.58 - $1.41 $28,429 - $69,112	49,016 Added 38.66%	175,815 $103,000
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.2 $25,579 - $54,813	-45,678 Reduced 26.48%	126,799 $135,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.86 $39,491 - $57,564	-66,935 Reduced 27.96%	172,477 $108,000
Q4 2022 Feb 14, 2023	BUY	$0.61 - $8.13 $3,481 - $46,397	5,707 Added 2.44%	239,412 $167,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $8.65 $26,689 - $316,252	36,561 Added 18.55%	233,705 $194,000
Q2 2022 Oct 27, 2022	SELL	$0.75 - $1.33 $78,644 - $139,462	-104,859 Reduced 34.72%	197,144 $151,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $78,644 - $139,462	-104,859 Reduced 34.72%	197,144 $151,000
Q1 2022 Oct 27, 2022	BUY	$1.09 - $1.83 $114,296 - $191,891	104,859 Added 53.19%	302,003 $393,000
Q1 2022 May 13, 2022	BUY	$1.09 - $1.83 $40,713 - $68,354	37,352 Added 14.11%	302,003 $393,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $313,895 - $544,984	-192,574 Reduced 42.12%	264,651 $434,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $3.45 $1.12 Million - $1.58 Million	457,225 New	457,225 $1.21 Million

Others Institutions Holding EVGN

# of Institutions

Shares Held

3.9M

Call Options Held

400

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $94.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account